Scientists test asthma drug in controlled dust mite chamber
NCT ID NCT05720325
Summary
This study is testing whether the medication dupilumab can help control asthma symptoms triggered by house dust mite allergies. Researchers will expose 88 adult participants with this type of asthma to controlled amounts of dust mites in a special chamber to measure their reactions. Participants will receive either dupilumab or a placebo for 18 weeks to see if the drug reduces allergy and asthma symptoms during these controlled exposures.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA, ALLERGIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Biogenics Research Chamber
RECRUITINGSan Antonio, Texas, 78229, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Texas Health Science Center at San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.